Prestige Biologics Co Ltd banner
P

Prestige Biologics Co Ltd
KOSDAQ:334970

Watchlist Manager
Prestige Biologics Co Ltd
KOSDAQ:334970
Watchlist
Price: 2 980 KRW -0.33% Market Closed
Market Cap: ₩231.7B

Cash Flow Statement

Cash Flow Statement
Prestige Biologics Co Ltd

Rotate your device to view
Cash Flow Statement
Currency: KRW
Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024 Dec-2024 Mar-2025 Jun-2025 Sep-2025
Operating Cash Flow
Net Income
(14 644)
(15 370)
(31 033)
(32 016)
(43 685)
(43 046)
(39 378)
(49 794)
(46 036)
(62 586)
(49 718)
(47 594)
(17 980)
(30 225)
(26 544)
(33 041)
(29 374)
(25 447)
(41 257)
(32 945)
(27 469)
(33 881)
Depreciation & Amortization
3 142
3 759
3 102
3 953
3 378
3 570
3 921
4 861
5 922
7 027
7 938
8 269
4 242
8 474
8 997
10 092
11 231
12 366
13 026
13 066
13 083
13 681
Stock-Based Compensation
1 304
0
787
1 413
1 250
1 372
795
697
575
387
295
292
171
306
88
5
(55)
(72)
0
0
0
0
Other Non-Cash Items
5 400
5 019
15 727
16 670
31 005
33 896
32 453
37 714
27 699
34 788
19 835
26 596
11 157
(6 650)
(4 795)
(7 803)
(9 771)
3 257
8 529
(1 082)
(2 764)
7 414
Cash Taxes Paid
0
0
0
0
(8)
15
(18)
(12)
(6)
(74)
(40)
0
12
0
0
0
0
0
0
0
0
0
Cash Interest Paid
150
45
147
195
491
632
818
1 169
2 915
4 504
4 764
6 164
2 614
6 200
3 919
2 840
3 355
2 634
5 517
5 416
4 686
2 829
Change in Working Capital
(9 408)
(8 620)
(1 126)
(1 947)
(8 295)
(7 017)
(22 865)
(32 892)
(14 970)
(19 773)
(12 245)
(6 771)
(1 870)
19 880
18 419
19 572
19 569
(9 914)
2 182
6 154
(1 176)
7 893
Cash from Operating Activities
(15 510)
N/A
(15 212)
+2%
(13 330)
+12%
(13 340)
0%
(17 597)
-32%
(12 597)
+28%
(25 869)
-105%
(40 111)
-55%
(27 384)
+32%
(40 543)
-48%
(34 190)
+16%
(19 500)
+43%
(4 450)
+77%
(8 521)
-91%
(3 922)
+54%
(11 180)
-185%
(8 345)
+25%
(19 737)
-136%
(17 521)
+11%
(14 808)
+15%
(18 327)
-24%
(4 892)
+73%
Investing Cash Flow
Capital Expenditures
(2 838)
(2 687)
(3 051)
(9 146)
(26 333)
(66 680)
(98 011)
(125 127)
(141 590)
(111 428)
(84 790)
(60 120)
(19 495)
(30 407)
(23 110)
(15 238)
(8 637)
(4 513)
(6 985)
(7 475)
(5 656)
(6 817)
Other Items
14 348
13 193
10 211
(39 786)
(24 958)
(16 285)
101
(4 097)
30 189
17 913
1 124
55 319
18
(371)
234
253
711
702
597
574
98
163
Cash from Investing Activities
11 510
N/A
10 506
-9%
7 160
-32%
(48 932)
N/A
(51 291)
-5%
(82 964)
-62%
(97 910)
-18%
(129 224)
-32%
(111 401)
+14%
(93 515)
+16%
(83 665)
+11%
(4 801)
+94%
(19 477)
-306%
(30 778)
-58%
(22 876)
+26%
(14 985)
+34%
(7 927)
+47%
(3 811)
+52%
(6 389)
-68%
(6 901)
-8%
(5 558)
+19%
(6 654)
-20%
Financing Cash Flow
Net Issuance of Common Stock
0
0
0
86 888
88 092
88 092
88 092
0
379
60 246
60 246
0
0
0
433
1 310
1 310
91 237
90 804
89 926
91 042
0
Net Issuance of Debt
4 379
4 087
(1 179)
(1 481)
12 802
13 028
68 249
164 532
148 626
91 487
36 260
(16 433)
53 979
56 238
53 381
9 797
(914)
(77 821)
(93 139)
(93 512)
(95 031)
(21 361)
Other
0
0
0
0
(28)
(28)
(28)
0
0
(43)
(43)
0
0
0
(51)
(51)
(52)
(92)
(51)
(51)
(51)
0
Cash from Financing Activities
4 379
N/A
4 087
-7%
(1 179)
N/A
85 407
N/A
100 865
+18%
101 091
+0%
156 312
+55%
165 708
+6%
149 005
-10%
151 690
+2%
96 463
-36%
43 770
-55%
53 979
+23%
56 238
+4%
53 763
-4%
11 057
-79%
345
-97%
13 324
+3 768%
(2 386)
N/A
(3 637)
-52%
(4 041)
-11%
(20 258)
-401%
Change in Cash
Net Change in Cash
379
N/A
(619)
N/A
(7 350)
-1 088%
23 135
N/A
31 977
+38%
5 530
-83%
32 533
+488%
(3 627)
N/A
10 219
N/A
17 632
+73%
(21 392)
N/A
19 469
N/A
30 052
+54%
16 939
-44%
26 965
+59%
(15 108)
N/A
(15 928)
-5%
(10 223)
+36%
(26 295)
-157%
(25 346)
+4%
(27 926)
-10%
(31 804)
-14%
Free Cash Flow
Free Cash Flow
(18 348)
N/A
(17 899)
+2%
(16 381)
+8%
(22 486)
-37%
(43 930)
-95%
(79 276)
-80%
(123 880)
-56%
(165 238)
-33%
(168 975)
-2%
(151 972)
+10%
(118 980)
+22%
(79 620)
+33%
(23 946)
+70%
(38 929)
-63%
(27 032)
+31%
(26 418)
+2%
(16 983)
+36%
(24 249)
-43%
(24 506)
-1%
(22 283)
+9%
(23 982)
-8%
(11 709)
+51%